Evidence suggests that antibodies may play a role in protecting against TB, either directly (Fab-mediated) or indirectly (Fc-mediated): monoclonal IgA therapy can reduce pulmonary Mtb burden (29), and adoptive transfer of antibodies from hosts with latent TB can improve macrophage functionality (30). Here, CD79A is linked to tuberculosis.